Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ryo Ko

7PUBLICATIONS

30CO-AUTHORS

Molecular targetsCancer diagnosisHaematological tumoursPredictive and prognostic markersInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Mar 04, 2026

Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or <i>HER2</i>-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Mar 16, 2023

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.

Koichiro Kanamori, Kentaro Suina, Takehito Shukuya

|Dec 16, 2022

Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.

Kana Kurokawa, Yoichiro Mitsuishi, Naoko Shimada

|Aug 12, 2022

Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated <i>EGFR</i>.

Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura

|Oct 07, 2021

Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.

Motoyasu Kato, Mikiko Mori, Keita Miura

|Mar 25, 2021

Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.

Fariz Nurwidya, Fumiyuki Takahashi, Wira Winardi

Pageof 2

Frequent Collaborators

4 joint publications

Takehito Shukuya

1 joint publications

Fariz Nurwidya

1 joint publications

Daisuke Hayakawa

1 joint publications

Motoyasu Kato

1 joint publications

Eisaku Miyauchi

1 joint publications

Satoshi Morita

1 joint publications

Yukio Hosomi

1 joint publications

Satoshi Ikeda

1 joint publications

Toshiyuki Harada

1 joint publications

Koichi Hagiwara

Frequent Collaborators

4 joint publications

Takehito Shukuya

1 joint publications

Fariz Nurwidya

1 joint publications

Daisuke Hayakawa

1 joint publications

Motoyasu Kato

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on : Feb 03, 2023

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on : Feb 03, 2023

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

See more related videos